Bausch Health
BHC
#3918
Rank
A$4.73 B
Marketcap
A$12.67
Share price
28.76%
Change (1 day)
41.25%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): A-$4.24

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is A-$4.20. In 2025 the company made an earnings per share (EPS) of A$0.60 an increase over its 2024 EPS that were of A-$0.17.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$4.24-810.42%
2025A$0.60-450%
2024A-$0.17-92.59%
2023A-$2.30160.89%
2022A-$0.88-76.64%
2021A-$3.7868.45%
2020A-$2.24-68.91%
2019A-$7.22-57.11%
2018A-$16.83-272.22%
2017A$9.77-199.29%
2016A-$9.84798.7%
2015A-$1.10-128.31%
2014A$3.87-204.62%
2013A-$3.70602.7%
2012A-$0.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
A-$0.13-96.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A-$1.35-67.80%๐Ÿ‡บ๐Ÿ‡ธ USA